#candel-therapeutics
Latest news and interesting information about candel-therapeutics.
BofA raises Candel price target to $9
BofA raises Candel price target to $9 after 39% improvement in prostate cancer survival data.
...
→
EN ▾
Goldman Sachs Upgrades Brambles on Subcontractor Exit10X Genomics SWOT: Profitability Test AheadOttobock shares drop 10% on short reportBOE considers temporary guardrails on stablecoin volumesIran to Azerbaijan: 12 kg Drug Smuggling FoiledCalifornia Water Atlas coming to AzerbaijanByron-Koks: Housing problem not simpleFinancial crisis at Kapaz FCMay 17 exam results not canceled - DIM statementKKR SWOT analysis: stock faces mixed signalsGoldman Sachs Upgrades Brambles on Subcontractor Exit10X Genomics SWOT: Profitability Test AheadOttobock shares drop 10% on short reportBOE considers temporary guardrails on stablecoin volumesIran to Azerbaijan: 12 kg Drug Smuggling FoiledCalifornia Water Atlas coming to AzerbaijanByron-Koks: Housing problem not simpleFinancial crisis at Kapaz FCMay 17 exam results not canceled - DIM statementKKR SWOT analysis: stock faces mixed signals